G
Gwen A. Huitt
Researcher at University of Colorado Denver
Publications - 31
Citations - 7859
Gwen A. Huitt is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Mycobacterium abscessus & Nontuberculous mycobacteria. The author has an hindex of 19, co-authored 31 publications receiving 6510 citations. Previous affiliations of Gwen A. Huitt include University of Colorado Boulder.
Papers
More filters
Journal ArticleDOI
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
David E. Griffith,Timothy R. Aksamit,Barbara A. Brown-Elliott,Antonino Catanzaro,Charles L. Daley,Fred M. Gordin,Steven M. Holland,Robert Horsburgh,Gwen A. Huitt,Michael F. Iademarco,Michael D. Iseman,Kenneth N. Olivier,Stephen J. Ruoss,C. Fordham von Reyn,Richard J. Wallace,Kevin L. Winthrop +15 more
TL;DR: Diagnostic Criteria of Nontuberculous Mycobacterial Lung Disease Key Laboratory Features of N TM Health Careand Hygiene-associated Disease Prevention Prophylaxis and Treatment of NTM Disease Introduction Methods.
Journal ArticleDOI
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Won-Jung Koh,Kyeongman Jeon,Nam Yong Lee,Bum Joon Kim,Yoon Hoh Kook,Seung Heon Lee,Young Kil Park,Chang Ki Kim,Sung Jae Shin,Gwen A. Huitt,Charles L. Daley,O Jung Kwon +11 more
TL;DR: In this paper, the authors compared clinical features and treatment outcomes between patients with M. abscessus lung disease and those with massiliense lung disease, and found that the clinical and radiographic manifestations of disease caused by each species were similar.
Journal ArticleDOI
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
TL;DR: Patients with M. abscessus pulmonary disease who are treated with multidrug antibiotic therapy and surgery or antibiotic therapy alone had similar clinical outcomes, however, surgical resection, in addition to antibiotics, may offer a prolonged microbiologic response.
Journal ArticleDOI
Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
Charles L. Daley,Jonathan M. Iaccarino,Christoph Lange,Emmanuelle Cambau,Richard J. Wallace,Claire Andrejak,Erik C. Böttger,Jan Brozek,David E. Griffith,Lorenzo Guglielmetti,Lorenzo Guglielmetti,Gwen A. Huitt,Shandra L Knight,Philip Leitman,Theodore K. Marras,Kenneth N. Olivier,Miguel Santin,Jason E. Stout,Enrico Tortoli,Jakko van Ingen,Dirk Wagner,Kevin L. Winthrop +21 more
TL;DR: This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, MycOBacterium kansasii, and Myc Cobacterium xenopi among the slowly growing NTM and MyCobacterius abscessus among the rapidly growing N TM.
Journal ArticleDOI
Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
Charles L. Daley,Jonathan M. Iaccarino,Christoph Lange,Emmanuelle Cambau,Richard J. Wallace,Claire Andrejak,Erik C. Böttger,Jan Brozek,David E. Griffith,Lorenzo Guglielmetti,Lorenzo Guglielmetti,Gwen A. Huitt,Shandra L Knight,Philip Leitman,Theodore K. Marras,Kenneth N. Olivier,Miguel Santin,Jason E. Stout,Enrico Tortoli,Jakko van Ingen,Dirk Wagner,Kevin L. Winthrop +21 more
TL;DR: This guideline focuses on pulmonary disease in adults (without cystic fibrosis or human immunodeficiency virus infection) caused by the most common NTM pathogens such as Mycobacterium avium complex, MycOBacterium kansasii, and Myc Cobacterium xenopi among the slowly growing NTM and MyCobacteria abscessus among the rapidly growing N TM.